ArticleThe Journal of biological chemistry2026
PhuS conformational dynamics are essential for DNA binding and heme-responsive control of the prrF operon in Pseudomonas aeruginosa.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In Pseudomonas aeruginosa chronic infections, heme is a primary source of the essential micronutrient iron. The cytoplasmic heme-binding protein, PhuS, regulates extracellular heme flux through its interaction with the iron-regulated heme oxygenase (HemO). Additionally, in its apo-state, PhuS modulates iron homeostasis by transcriptionally regulating the prrF1,2 sRNA genes. These two functions are mutually exclusive and dependent on the conformational rearrangement of PhuS upon heme binding and coordination. Herein, we characterize a PhuS R25A variant that shows similar heme-binding kinetics and transfer of heme to HemO as PhuS WT, while DNA-binding to the prrF1 promoter is completely lost, successfully uncoupling the two functions. HDX-MS analysis revealed an overall decrease in conformational dynamics of apo- and holo-PhuS R25A compared with their WT counterparts, demonstrating the importance of conformational flexibility for DNA binding. qRT-PCR and Northern blot analysis comparing the phuSR25A allelic mutant strain to the PAO1 WT showed a significant decrease in PrrF and PrrH levels and revealed PhuS-dependent differences in regulation over PrrF1 and PrrF2, altering the relative ratio of these two sRNAs in a heme-specific manner that is distinct from iron. By removing its DNA-binding function, we elucidated the direct effects of PhuS binding on PrrF expression, separate from its effects on heme transfer and utilization. The contrasting effects on gene expression of the tandem sRNAs PrrF1 and PrrF2 in iron and heme and the resulting distinct mRNA profiles may allow the bacteria a fitness advantage in establishing chronic infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.